(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are NORTHERN DRILLING, ADC SIIC, and AKASTOR.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| NORTHERN DRILLING (NODL.OL) | 2.81 | 63.85% | 2023-12-11 12:41:34 |
| ADC SIIC (ALDV.PA) | 0.08 | 20.97% | 2023-12-11 12:44:50 |
| AKASTOR (AKAST.OL) | 12.66 | 15.72% | 2023-12-11 12:24:16 |
| SCHIBSTED SER. A (SCHA.OL) | 316.00 | 15.24% | 2023-12-11 12:42:50 |
| SCHIBSTED SER. B (SCHB.OL) | 296.60 | 13.47% | 2023-12-11 12:42:52 |
| CLARANOVA (CLA.PA) | 1.97 | 8.72% | 2023-12-11 13:01:13 |
| ITERA (ITERA.OL) | 12.15 | 8.48% | 2023-12-11 12:40:38 |
| MAAT PHARMA (MAAT.PA) | 7.00 | 8.02% | 2023-12-11 13:06:02 |
| MEMSCAP REGPT (MEMS.PA) | 6.24 | 7.96% | 2023-12-11 13:20:13 |
| SEQUANA MEDICAL (SEQUA.BR) | 3.40 | 7.94% | 2023-12-11 12:21:20 |
The three biggest losers today are SOLVAY, CHAUSSERIA, and REINET INVESTMENTS.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| SOLVAY (SOLB.BR) | 21.37 | -26.56% | 2023-12-11 12:21:31 |
| CHAUSSERIA (CHSR.PA) | 7.20 | -20% | 2023-12-11 13:01:09 |
| REINET INVESTMENTS (REINA.AS) | 20.80 | -14.75% | 2023-12-11 12:03:42 |
| ABEO (ABEO.PA) | 14.55 | -9.35% | 2023-12-11 12:44:32 |
| METABOLIC EXPLORER (METEX.PA) | 0.35 | -8.09% | 2023-12-11 13:20:20 |
| BORREGAARD (BRG.OL) | 159.00 | -7.56% | 2023-12-11 12:25:10 |
| AGFA-GEVAERT (AGFB.BR) | 1.36 | -6.98% | 2023-12-11 12:04:49 |
| PCI BIOTECH HOLD (PCIB.OL) | 2.14 | -6.55% | 2023-12-11 12:42:06 |
| SIKRI GROUP (SIKRI.OL) | 5.84 | -6.11% | 2023-12-11 12:43:04 |
| SOLSTAD OFFSHORE (SOFF.OL) | 30.10 | -5.94% | 2023-12-11 12:43:11 |
Winners today
1. NORTHERN DRILLING (NODL.OL)
63.85% Price Change
Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING jumping 63.85% to €2.81 on Monday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.37% to €1,299.18, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-6.15.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.
Yearly Top and Bottom Value
NORTHERN DRILLING’s stock is valued at kr2.81 at 21:40 EST, way below its 52-week high of kr34.90 and way higher than its 52-week low of kr0.31.
More news about NORTHERN DRILLING.
2. ADC SIIC (ALDV.PA)
20.97% Price Change
Alliance Developpement Capital SIIC (ADC SIIC) is a publicly owned real estate investment firm. The firm specializes in owning and managing residential real estate properties. It primarily invests in properties in Paris and its suburbs. The firm was formerly known as AD Capital SA. Alliance Developpement Capital is based in Saint-Josse-Ten-Noode, Belgium.
CAC 40 ended the session with ADC SIIC rising 20.97% to €0.08 on Monday, after five successive sessions in a row of losses. CAC 40 jumped 0.33% to €7,551.53, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.45%.
Moving Average
ADC SIIC’s worth is way higher than its 50-day moving average of €0.06 and way higher than its 200-day moving average of €0.07.
More news about ADC SIIC.
3. AKASTOR (AKAST.OL)
15.72% Price Change
Akastor ASA operates as an oilfield services investment company in Norway, the United Kingdom, Denmark, Australia, and internationally. The company offers vessel-based subsea well construction and intervention services to the oil and gas industry. It also provides well design and drilling project management services; reservoir and field management services; and rig procurement, tailored training, software, and technical manpower services, as well as well and reservoir consultancy services. In addition, the company offers a range of offshore drilling equipment products and packages. It owns five offshore vessels. Akastor ASA was founded in 1841 and is based in Bærum, Norway.
Oslo Børs Benchmark Index_GI ended the session with AKASTOR jumping 15.72% to €12.66 on Monday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.37% to €1,299.18, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, AKASTOR has a trailing twelve months EPS of kr-1.83.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.13%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AKASTOR’s EBITDA is 3.76.
Volume
Today’s last reported volume for AKASTOR is 984220 which is 637.56% above its average volume of 133441.
Yearly Top and Bottom Value
AKASTOR’s stock is valued at kr12.66 at 21:40 EST, way under its 52-week high of kr14.14 and way higher than its 52-week low of kr8.20.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 133.3% and a negative 102.9%, respectively.
More news about AKASTOR.
4. SCHIBSTED SER. A (SCHA.OL)
15.24% Price Change
Schibsted ASA, together with its subsidiaries, operates as a media company. The company operates through Nordic Marketplaces, News Media, eCommerce & Distribution, and Financial Services & Ventures segments. It operates online classifieds that provide technology-based services to connect buyers and sellers, and facilitate transactions, including job offers, real estate, cars, travel, consumer goods, and others. The company also publishes newspapers under the VG, Aftenposten, E24, Bergens Tidende, Stavanger Aftenblad, Aftonbladet, Svenska Dagbladet, and Omni brands in paper and digital format; and operates Podme, a podcast platform. In addition, the company distributes newspapers and parcels for businesses and consumers under the Helthjem and Morgenlevering brands. Further, it has a portfolio of digital companies, which include Lendo that offers digital marketplaces for consumer lending; Prisjakt, which offers price comparison for consumers; Ingrid, a delivery platform; Tørn, a marketplace for surplus construction goods; and Savr, a fund platform. The company operates in Norway, Sweden, Finland, Denmark, other European countries, and internationally. Schibsted ASA was founded in 1839 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with SCHIBSTED SER. A jumping 15.24% to €316.00 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.37% to €1,299.18, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, SCHIBSTED SER. A has a trailing twelve months EPS of kr65.75.
PE Ratio
SCHIBSTED SER. A has a trailing twelve months price to earnings ratio of 4.81. Meaning, the purchaser of the share is investing kr4.81 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.56%.
Sales Growth
SCHIBSTED SER. A’s sales growth is 2.9% for the ongoing quarter and 6.8% for the next.
More news about SCHIBSTED SER. A.
5. SCHIBSTED SER. B (SCHB.OL)
13.47% Price Change
Schibsted ASA, together with its subsidiaries, operates as a media company. The company operates through Nordic Marketplaces, News Media, eCommerce & Distribution, and Financial Services & Ventures segments. It operates online classifieds that provide technology-based services to connect buyers and sellers, and facilitate transactions, including job offers, real estate, cars, travel, consumer goods, and others. The company also publishes newspapers under the VG, Aftenposten, E24, Bergens Tidende, Stavanger Aftenblad, Aftonbladet, Svenska Dagbladet, and Omni brands in paper and digital format; and operates Podme, a podcast platform. In addition, the company distributes newspapers and parcels for businesses and consumers under the Helthjem and Morgenlevering brands. Further, it has a portfolio of digital companies, which include Lendo that offers digital marketplaces for consumer lending; Prisjakt, which offers price comparison for consumers; Ingrid, a delivery platform; Tørn, a marketplace for surplus construction goods; and Savr, a fund platform. The company operates in Norway, Sweden, Finland, Denmark, other European countries, and internationally. Schibsted ASA was founded in 1839 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with SCHIBSTED SER. B rising 13.47% to €296.60 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.37% to €1,299.18, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, SCHIBSTED SER. B has a trailing twelve months EPS of kr65.77.
PE Ratio
SCHIBSTED SER. B has a trailing twelve months price to earnings ratio of 4.51. Meaning, the purchaser of the share is investing kr4.51 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.56%.
Volatility
SCHIBSTED SER. B’s last week, last month’s, and last quarter’s current intraday variation average was 1.01%, 0.76%, and 1.70%.
SCHIBSTED SER. B’s highest amplitude of average volatility was 1.32% (last week), 1.77% (last month), and 1.70% (last quarter).
Yearly Top and Bottom Value
SCHIBSTED SER. B’s stock is valued at kr296.60 at 21:40 EST, way higher than its 52-week high of kr264.80.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SCHIBSTED SER. B’s stock is considered to be oversold (<=20).
Moving Average
SCHIBSTED SER. B’s worth is way higher than its 50-day moving average of kr225.79 and way higher than its 200-day moving average of kr198.62.
More news about SCHIBSTED SER. B.
6. CLARANOVA (CLA.PA)
8.72% Price Change
Claranova SE, a technology company, engages in personalized e-commerce, software publishing, and internet of things (IoT) management in France, the United States, the United Kingdom, Germany, other European countries, and internationally. It operates in three segments: PlanetArt, Avanquest, and myDevices. The PlanetArt segment offers photos, frames, personalized books, and FreePrints mobile applications. The Avanquest segment provides antivirus, ad blocker, cleaning, and optimization tools under the Adaware brand; document management tools under the SodaPDF brand; and photo editor software and applications developed under the inPixio brand. The myDevices segment offers IoT solutions. Claranova SE was incorporated in 1984 and is headquartered in Courbevoie, France.
CAC 40 ended the session with CLARANOVA rising 8.72% to €1.97 on Monday while CAC 40 rose 0.33% to €7,551.53.
Earnings Per Share
As for profitability, CLARANOVA has a trailing twelve months EPS of €-0.23.
Volatility
CLARANOVA’s last week, last month’s, and last quarter’s current intraday variation average was 4.15%, 1.40%, and 2.82%.
CLARANOVA’s highest amplitude of average volatility was 5.37% (last week), 2.91% (last month), and 2.82% (last quarter).
Moving Average
CLARANOVA’s worth is way above its 50-day moving average of €1.45 and way above its 200-day moving average of €1.73.
Volume
Today’s last reported volume for CLARANOVA is 216352 which is 154.48% above its average volume of 85017.
More news about CLARANOVA.
7. ITERA (ITERA.OL)
8.48% Price Change
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ITERA jumping 8.48% to €12.15 on Monday while Oslo Børs Benchmark Index_GI jumped 0.37% to €1,299.18.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.76.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 15.99. Meaning, the purchaser of the share is investing kr15.99 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 86.07%.
Volume
Today’s last reported volume for ITERA is 963570 which is 4431.46% above its average volume of 21264.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ITERA’s EBITDA is 1.11.
Moving Average
ITERA’s value is higher than its 50-day moving average of kr11.68 and way under its 200-day moving average of kr13.59.
More news about ITERA.
8. MAAT PHARMA (MAAT.PA)
8.02% Price Change
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.
CAC 40 ended the session with MAAT PHARMA rising 8.02% to €7.00 on Monday while CAC 40 jumped 0.33% to €7,551.53.
Earnings Per Share
As for profitability, MAAT PHARMA has a trailing twelve months EPS of €-1.4.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.11%.
More news about MAAT PHARMA.
9. MEMSCAP REGPT (MEMS.PA)
7.96% Price Change
MEMSCAP, S.A. provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical, and biomedical markets worldwide. The company offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. It also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories. In addition, the company supplies optical MEMS chips for variable optical attenuators in optical telecommunication markets; and provides the multi-user MEMS processes. Further, it offers mounting brackets, snap holders, non-sterile and sterile domes, and monitoring line sets. MEMSCAP, S.A. was founded in 1997 and is based in Crolles, France.
CAC 40 ended the session with MEMSCAP REGPT jumping 7.96% to €6.24 on Monday while CAC 40 jumped 0.33% to €7,551.53.
Earnings Per Share
As for profitability, MEMSCAP REGPT has a trailing twelve months EPS of €0.15.
PE Ratio
MEMSCAP REGPT has a trailing twelve months price to earnings ratio of 41.6. Meaning, the purchaser of the share is investing €41.6 for every euro of annual earnings.
More news about MEMSCAP REGPT.
10. SEQUANA MEDICAL (SEQUA.BR)
7.94% Price Change
Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
BEL 20 ended the session with SEQUANA MEDICAL jumping 7.94% to €3.40 on Monday, following the last session’s upward trend. BEL 20 jumped 0.26% to €3,704.21, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.
Yearly Top and Bottom Value
SEQUANA MEDICAL’s stock is valued at €3.40 at 21:40 EST, way under its 52-week high of €6.44 and way above its 52-week low of €2.22.
Volatility
SEQUANA MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was 4.10%, 1.02%, and 3.65%.
SEQUANA MEDICAL’s highest amplitude of average volatility was 5.43% (last week), 3.45% (last month), and 3.65% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SEQUANA MEDICAL’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for SEQUANA MEDICAL is 28290 which is 188.17% above its average volume of 9817.
More news about SEQUANA MEDICAL.
Losers Today
1. SOLVAY (SOLB.BR)
-26.56% Price Change
Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, phenols and derivatives, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the food, flavors, and fragrances industries, as well as value-added intermediates used in monomers and polymers, pharmaceuticals, agrochemicals, and electronics. This segment also provides various products for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications; and PROBAN, a technological process that offers durable flame retardant properties to cotton-based textiles. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.
BEL 20 ended the session with SOLVAY dropping 26.56% to €21.37 on Monday, following the last session’s downward trend. BEL 20 jumped 0.26% to €3,704.21, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, SOLVAY has a trailing twelve months EPS of €10.24.
PE Ratio
SOLVAY has a trailing twelve months price to earnings ratio of 2.09. Meaning, the purchaser of the share is investing €2.09 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.93%.
Moving Average
SOLVAY’s worth is way under its 50-day moving average of €102.14 and way under its 200-day moving average of €103.91.
Yearly Top and Bottom Value
SOLVAY’s stock is valued at €21.37 at 21:40 EST, way below its 52-week low of €92.14.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 15, 2024, the estimated forward annual dividend rate is 4.13 and the estimated forward annual dividend yield is 3.68%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SOLVAY’s stock is considered to be oversold (<=20).
More news about SOLVAY.
2. CHAUSSERIA (CHSR.PA)
-20% Price Change
Chausseria designs, manufactures, and markets women's shoes. The company markets its products under the Chausseria and Janie Philip brands. Chausseria is headquartered in Paris, France.
CAC 40 ended the session with CHAUSSERIA falling 20% to €7.20 on Monday while CAC 40 rose 0.33% to €7,551.53.
Earnings Per Share
As for profitability, CHAUSSERIA has a trailing twelve months EPS of €1.06.
PE Ratio
CHAUSSERIA has a trailing twelve months price to earnings ratio of 6.79. Meaning, the purchaser of the share is investing €6.79 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.34%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.7%, now sitting on 2.87M for the twelve trailing months.
More news about CHAUSSERIA.
3. REINET INVESTMENTS (REINA.AS)
-14.75% Price Change
Reinet Investments S.C.A. operates as a securitization vehicle in Luxembourg. The company, through its subsidiary, Reinet Fund S.C.A., F.I.S., invests in assets. Reinet Investments Manager S.A. operates as a general partner of Reinet Investments S.C.A. The company was formerly known as Richemont S.A. and changed its name to Reinet Investments S.C.A. in October 2008. Reinet Investments S.C.A. was incorporated in 1979 and is based in Luxembourg City, Luxembourg.
AEX-Index ended the session with REINET INVESTMENTS dropping 14.75% to €20.80 on Monday while AEX-Index rose 0.59% to €786.45.
Earnings Per Share
As for profitability, REINET INVESTMENTS has a trailing twelve months EPS of €-0.66.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, REINET INVESTMENTS’s stock is considered to be oversold (<=20).
More news about REINET INVESTMENTS.
4. ABEO (ABEO.PA)
-9.35% Price Change
Abéo SA engages in the design, manufacture, and distribution of sports and leisure equipment in France and internationally. It offers gymnastics equipment and facilities, gym mats, team sports equipment, physical education, trampoline parks, and artificial climbing walls, as well as changing room layouts, cabins, cupboards, and lockers. It offers its products under the GYMNOVA, JANSSEN-FRITSEN, SPIETH GYMNASTICS, SCHELDE SPORTS, SPIETH AMERICA, SPORTSAFE, ERHARD SPORT, ADEC SPORT, O'JUMP, CANNICE, BOSAN, PCV, VOGOSCOPE, BIGAIRBAG, BRICK, EP, CLIP'N CLIMB, TOP30, DOCK 39, FUN SPOT, CLIMBAT, FRANCE EQUIPEMENT, META, PROSPEC, NAVIC, SANITEC, SUFFIXE, and SANELITE brands. The company was founded in 1955 and is headquartered in Rioz, France.
CAC 40 ended the session with ABEO dropping 9.35% to €14.55 on Monday while CAC 40 jumped 0.33% to €7,551.53.
Earnings Per Share
As for profitability, ABEO has a trailing twelve months EPS of €0.89.
PE Ratio
ABEO has a trailing twelve months price to earnings ratio of 16.35. Meaning, the purchaser of the share is investing €16.35 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6%.
Yearly Top and Bottom Value
ABEO’s stock is valued at €14.55 at 21:40 EST, way below its 52-week high of €21.10 and above its 52-week low of €14.40.
Volume
Today’s last reported volume for ABEO is 3378 which is 305.03% above its average volume of 834.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 27, 2023, the estimated forward annual dividend rate is 0.33 and the estimated forward annual dividend yield is 2.03%.
Volatility
ABEO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.56%, a negative 0.62%, and a positive 1.18%.
ABEO’s highest amplitude of average volatility was 0.56% (last week), 0.91% (last month), and 1.18% (last quarter).
More news about ABEO.
5. METABOLIC EXPLORER (METEX.PA)
-8.09% Price Change
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.
CAC 40 ended the session with METABOLIC EXPLORER falling 8.09% to €0.35 on Monday, following the last session’s upward trend. CAC 40 jumped 0.33% to €7,551.53, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, METABOLIC EXPLORER’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth declined by 46.2%, now sitting on 168.16M for the twelve trailing months.
Yearly Top and Bottom Value
METABOLIC EXPLORER’s stock is valued at €0.35 at 21:40 EST, way under its 52-week high of €1.70 and way higher than its 52-week low of €0.22.
Moving Average
METABOLIC EXPLORER’s value is way under its 50-day moving average of €0.41 and way below its 200-day moving average of €0.85.
More news about METABOLIC EXPLORER.
6. BORREGAARD (BRG.OL)
-7.56% Price Change
Borregaard ASA develops, produces, and markets specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates through three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers for a range of applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
Oslo Børs Benchmark Index_GI ended the session with BORREGAARD dropping 7.56% to €159.00 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.37% to €1,299.18, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, BORREGAARD has a trailing twelve months EPS of kr9.36.
PE Ratio
BORREGAARD has a trailing twelve months price to earnings ratio of 16.99. Meaning, the purchaser of the share is investing kr16.99 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.37%.
Sales Growth
BORREGAARD’s sales growth is 6.4% for the present quarter and 2.9% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 19, 2023, the estimated forward annual dividend rate is 3.25 and the estimated forward annual dividend yield is 2.08%.
Volume
Today’s last reported volume for BORREGAARD is 307653 which is 268.29% above its average volume of 83535.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 1.7% and positive 15.2% for the next.
More news about BORREGAARD.
7. AGFA-GEVAERT (AGFB.BR)
-6.98% Price Change
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide. The company's Offset Solutions segment provides commercial, newspaper, and packaging printers; integrated prepress and printing solutions, including computer-to-plate systems using digital offset printing plates, pressroom supplies, and software for workflow optimization, color management, screening, and print standardization; and security printing software solutions. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides picture archiving and communication systems; hospital information system and clinical information systems; and integrated care solutions. Its Digital Print & Chemicals segment offers inkjet printers for sign and display printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; membranes to the hydrogen production industry, as well as for printable synthetic papers This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
BEL 20 ended the session with AGFA-GEVAERT falling 6.98% to €1.36 on Monday, after two sequential sessions in a row of gains. BEL 20 rose 0.26% to €3,704.21, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, AGFA-GEVAERT has a trailing twelve months EPS of €-1.34.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AGFA-GEVAERT’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for AGFA-GEVAERT is 266820 which is 6.37% above its average volume of 250840.
More news about AGFA-GEVAERT.
8. PCI BIOTECH HOLD (PCIB.OL)
-6.55% Price Change
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD dropping 6.55% to €2.14 on Monday while Oslo Børs Benchmark Index_GI rose 0.37% to €1,299.18.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.79.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.
Yearly Top and Bottom Value
PCI BIOTECH HOLD’s stock is valued at kr2.14 at 21:40 EST, way under its 52-week high of kr5.93 and way higher than its 52-week low of kr1.20.
More news about PCI BIOTECH HOLD.
9. SIKRI GROUP (SIKRI.OL)
-6.11% Price Change
Sikri Group ASA provides software solutions in Norway. It operates through four segments: Public, Private, Consumer, and Metria. The Public segment provides software solution for case processing, building applications, archiving, and document management to public sector. The Private segment offers digital solutions based on real estate data. The Consumer segment delivers digital platforms where property owners can take control of the condition and value of their property through documentation and automatic valuation models. The Metria segment offers services and solutions within geodata; property and real estate; consultancy and analysis; and cloud solutions. The company also offers eByggesak, a software solution for electronic building permit applications; PixEdit, a software for automating the processing of scanning, data capture, digitalization and optimization, interactive editing, converting all types of files/ documents, and enriching them with the right valuable digital content; Samsvar, a system that helps consumers keep track of their legal requirements related to privacy and information security; Infoland, a data source for the real estate market; data services that include services connected to the land registry and technical information; and digital settlement process in real estate transactions. In, addition it offers Byggesøknaden, a digital building application for professionals; Propfinder, a map service designed for property developers; Boligmappa, a market platform aggregating data on homes from public registers, craftsmen, and homeowners; and VIRDI, a business-to-consumer real estate platform covering residential properties through their lifecycle enabling context-based sales and marketing. Sikri Group ASA was incorporated in 2019 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with SIKRI GROUP sliding 6.11% to €5.84 on Monday while Oslo Børs Benchmark Index_GI rose 0.37% to €1,299.18.
Earnings Per Share
As for profitability, SIKRI GROUP has a trailing twelve months EPS of kr-0.07.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.19%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 1.15B for the twelve trailing months.
Volume
Today’s last reported volume for SIKRI GROUP is 22334 which is 63.94% below its average volume of 61936.
More news about SIKRI GROUP.
10. SOLSTAD OFFSHORE (SOFF.OL)
-5.94% Price Change
Solstad Offshore ASA operates offshore service vessels and maritime services to offshore energy industry. It owns and operates platform supply vessel, anchor handling tug support vessel, and construction service vessels. The company offers subsea construction and renewable energy services, such as geotechnical work, walk to work services, grouting, SURF operations, cable laying and repair, trenching and burial, ROV support, installation of subsea equipment, survey work, IMR operations, node seismic operations, and diving and topside maintenance work. It operates a fleet of 27 construction service vessels, 20 anchor handling tug support vessels, and 39 platform supply vessels. The company was founded in 1964 and is headquartered in Skudeneshavn, Norway.
Oslo Børs Benchmark Index_GI ended the session with SOLSTAD OFFSHORE sliding 5.94% to €30.10 on Monday while Oslo Børs Benchmark Index_GI rose 0.37% to €1,299.18.
Earnings Per Share
As for profitability, SOLSTAD OFFSHORE has a trailing twelve months EPS of kr0.6.
PE Ratio
SOLSTAD OFFSHORE has a trailing twelve months price to earnings ratio of 50.17. Meaning, the purchaser of the share is investing kr50.17 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.44%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SOLSTAD OFFSHORE’s EBITDA is 2.3.
Moving Average
SOLSTAD OFFSHORE’s worth is way higher than its 50-day moving average of kr27.11 and way above its 200-day moving average of kr26.24.
Volatility
SOLSTAD OFFSHORE’s last week, last month’s, and last quarter’s current intraday variation average was 4.18%, 1.60%, and 3.74%.
SOLSTAD OFFSHORE’s highest amplitude of average volatility was 6.53% (last week), 3.98% (last month), and 3.74% (last quarter).
More news about SOLSTAD OFFSHORE.
Stay up to date with our winners and losers daily report
